-
Designing synthetic extracellular matrices to support neurodegenerative disease modeling
https://braincanada.ca/fr/subventions-financées/designing-synthetic-extracellular-matrices-to-support-neurodegenerative-disease-modelingWe propose to develop chemically defined synthetic extracellular matrices to support neural cells in longterm stable cell culture. Project Overview We propose to develop chemically defined synthetic extracellular matrices to support neural cells in longterm stable cell culture. Human induced...
-
Detecting Behaviours of Risk in Nursing Homes using Deep Learning
https://braincanada.ca/fr/subventions-financées/detecting-behaviours-of-risk-in-nursing-homes-using-deep-learningMany people with dementia (PwD) live in nursing homes, which often suffer from a lack of skilled staff to support and monitor the safety of residents. Project Overview Many people with dementia (PwD) live in nursing homes, which often suffer from a lack of skilled staff to support and monitor the...
-
Detection and prevention of pypermutant glioma in children and young adults
https://braincanada.ca/fr/subventions-financées/detection-and-prevention-of-pypermutant-glioma-in-children-and-young-adultsNeed for project: Replication repair deficiency (RRD) is a genetic condition that significantly increases the risk of developing cancer, particularly early in life. Project Overview Need for project: Replication repair deficiency (RRD) is a genetic condition that significantly increases the risk of...
-
Detection of misfolded TDP-43 in CSF of ALS cases: Diagnostic potential of confirmation-specific antibodies
https://braincanada.ca/fr/subventions-financées/detection-of-misfolded-tdp-43-in-csf-of-als-cases-diagnostic-potential-of-confirmation-specific-antibodiesA more streamlined way to diagnose ALS earlier is desperately needed as current methods can take up to two years and rely heavily on ruling out other conditions that share similar symptoms. Project Overview A more streamlined way to diagnose ALS earlier is desperately needed as current methods can...
-
Detection of tandem repeat expansion in neurological disorders
https://braincanada.ca/fr/subventions-financées/detection-of-tandem-repeat-expansion-in-neurological-disordersIn the past decade, rapid development of software has allowed detection of a wide variety of genetic risk factors in brain disorders. Project Overview In the past decade, rapid development of software has allowed detection of a wide variety of genetic risk factors in brain disorders. It has...
-
Determination of hypothalamic neuropathology and metabolic defects in ALS
https://braincanada.ca/fr/subventions-financées/determination-of-hypothalamic-neuropathology-and-metabolic-defects-in-alsAmyotrophic lateral sclerosis (ALS) is a motor neuron disease leading to paralysis and death within 2-5 years from disease onset. Project Overview Amyotrophic lateral sclerosis (ALS) is a motor neuron disease leading to paralysis and death within 2-5 years from disease onset. Other hallmark...
-
Determining the contribution of acute viral infection on the onset and progression of ALS
https://braincanada.ca/fr/subventions-financées/determining-the-contribution-of-acute-viral-infection-on-the-onset-and-progression-of-alsAlmost all amyotrophic lateral sclerosis (ALS) is accompanied by neuronal cytoplasmic aggregates of TAR DNA-binding protein-43 (TDP-43). Project Overview Almost all amyotrophic lateral sclerosis (ALS) is accompanied by neuronal cytoplasmic aggregates of TAR DNA-binding protein-43 (TDP-43). TDP-43...
-
Developing a digital signature of care-related activities and burden
https://braincanada.ca/fr/subventions-financées/developing-a-digital-signature-of-care-related-activities-and-burdenWe propose to develop a digital signature that identifies the level of care partner burden associated with person living with dementia (PLWD)/care partner dyads living in the community. Project Overview We propose to develop a digital signature that identifies the level of care partner burden...
-
Developing a Magnetic Resonance Imaging (MRI) based pH Mapping Tool for Clinical Stroke Assessment
https://braincanada.ca/fr/subventions-financées/developing-a-magnetic-resonance-imaging-mri-based-ph-mapping-tool-for-clinical-stroke-assessmentAcute ischemic stroke represents the vast majority of strokes. Project Overview Acute ischemic stroke represents the vast majority of strokes. The priority in mitigating the impact is getting to hospital quickly. Once at the hospital we use medical imaging to determine the type of stroke and type...
-
Developing a new model to study microglia and macrophage function in slowly expanding lesions of multiple sclerosis
https://braincanada.ca/fr/subventions-financées/developing-a-new-model-to-study-microglia-and-macrophage-function-in-slowly-expanding-lesions-of-multiple-sclerosisMultiple sclerosis (MS) is a neurodegenerative disease in the brain and spinal cord of the central nervous system (CNS). Project Overview Multiple sclerosis (MS) is a neurodegenerative disease in the brain and spinal cord of the central nervous system (CNS). Canada has amongst the highest rate of...